8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.25%
Positive revenue growth while 3141.T is negative. John Neff might see a notable competitive edge here.
6.66%
Positive gross profit growth while 3141.T is negative. John Neff would see a clear operational edge over the competitor.
45.88%
Positive EBIT growth while 3141.T is negative. John Neff might see a substantial edge in operational management.
51.13%
Positive operating income growth while 3141.T is negative. John Neff might view this as a competitive edge in operations.
46.91%
Positive net income growth while 3141.T is negative. John Neff might see a big relative performance advantage.
46.89%
Positive EPS growth while 3141.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
46.89%
Positive diluted EPS growth while 3141.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.00%
Share reduction while 3141.T is at 0.10%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
68.51%
10Y revenue/share CAGR at 50-75% of 3141.T's 133.36%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
64.78%
5Y revenue/share CAGR at 50-75% of 3141.T's 92.03%. Martin Whitman would worry about a lagging mid-term growth trajectory.
35.69%
3Y revenue/share CAGR similar to 3141.T's 39.13%. Walter Schloss would assume both companies experience comparable short-term cycles.
100.00%
Positive long-term OCF/share growth while 3141.T is negative. John Neff would see a structural advantage in sustained cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
202.11%
Similar net income/share CAGR to 3141.T's 210.18%. Walter Schloss would see parallel tailwinds or expansions for both firms.
95.22%
5Y net income/share CAGR similar to 3141.T's 103.21%. Walter Schloss might see both on parallel mid-term trajectories.
40.35%
3Y net income/share CAGR similar to 3141.T's 40.20%. Walter Schloss would attribute it to shared growth factors or demand patterns.
201.46%
10Y equity/share CAGR at 75-90% of 3141.T's 249.47%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
125.07%
5Y equity/share CAGR above 1.5x 3141.T's 81.80%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
58.34%
3Y equity/share CAGR above 1.5x 3141.T's 38.04%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-47.90%
Firm’s AR is declining while 3141.T shows 7.93%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-6.06%
Inventory is declining while 3141.T stands at 9.31%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.11%
Asset growth at 50-75% of 3141.T's 1.66%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
3.35%
BV/share growth above 1.5x 3141.T's 1.11%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-4.77%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-1.60%
We cut SG&A while 3141.T invests at 2.04%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.